Cargando…

Multiple sclerosis and COVID‐19: The Swedish experience

The COVID‐19 pandemic has brought challenges for healthcare management of patients with multiple sclerosis (MS). Concerns regarding vulnerability to infections and disease‐modifying therapies (DMTs) and their complications have been raised. Recent published guidelines on the use of DMTs in relation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Landtblom, Anne‐Marie, Berntsson, Shala G., Boström, Inger, Iacobaeus, Ellen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222873/ https://www.ncbi.nlm.nih.gov/pubmed/34028810 http://dx.doi.org/10.1111/ane.13453

Ejemplares similares

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
por: Katsarogiannis, Evangelos, et al.
Publicado: (2023)

Cerebellar ataxia and intrathecal baclofen therapy: Focus on patients´ experiences
por: Berntsson, Shala Ghaderi, et al.
Publicado: (2017)

New data identify an increasing sex ratio of multiple sclerosis in Sweden
por: Westerlind, Helga, et al.
Publicado: (2014)

Ecstatic and gelastic seizures relate to the hypothalamus
por: Roodakker, Kenney Roy, et al.
Publicado: (2020)

Ecstatic and gelastic seizures related to the hypothalamus
por: Roodakker, Kenney Roy, et al.
Publicado: (2020)

A comprehensive diagnostic approach in suspected neurosarcoidosis
por: Berntsson, Shala Ghaderi, et al.
Publicado: (2023)

Inventory study of an early pandemic COVID-19 cohort in South-Eastern Sweden, focusing on neurological manifestations
por: Ahmadpour, Doryaneh, et al.
Publicado: (2023)

Aggressive multiple sclerosis (2): Treatment
por: Arrambide, Georgina, et al.
Publicado: (2020)

Fatal Acute Hemorrhagic Encephalomyelitis and Antiphospholipid Antibodies following SARS-CoV-2 Vaccination: A Case Report
por: Kits, Annika, et al.
Publicado: (2022)

The study circle as a tool in multiple sclerosis patient education in Sweden
por: Landtblom, Anne-Marie, et al.
Publicado: (2008)

Aggressive multiple sclerosis (1): Towards a definition of the phenotype
por: Iacobaeus, Ellen, et al.
Publicado: (2020)

Thalamo-striato-cortical determinants to fatigue in multiple sclerosis
por: Engström, Maria, et al.
Publicado: (2013)

Guidelines for the use of magnetic resonance imaging in diagnosing and monitoring the treatment of multiple sclerosis: recommendations of the Swedish Multiple Sclerosis Association and the Swedish Neuroradiological Society
por: Vågberg, M., et al.
Publicado: (2016)

Smouldering multiple sclerosis: the ‘real MS’
por: Giovannoni, Gavin, et al.
Publicado: (2022)

Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study
por: Flensner, Gullvi, et al.
Publicado: (2013)

Normal Appearing and Diffusely Abnormal White Matter in Patients with Multiple Sclerosis Assessed with Quantitative MR
por: West, Janne, et al.
Publicado: (2014)

Validity and reliability of the Patient Health Questionnaire-8 in Swedish for individuals with systemic sclerosis
por: Mattsson, Malin, et al.
Publicado: (2020)

The validity and reliability of the Swedish version of the Satisfaction with appearance scale for individuals with systemic sclerosis
por: Mattsson, Malin, et al.
Publicado: (2022)

Case report: a novel deep intronic splice-altering variant in DMD as a cause of Becker muscular dystrophy
por: Berntsson, Shala Ghaderi, et al.
Publicado: (2023)

Does Intrathecal Baclofen Have a Place in the Treatment of Painful Spasms in Friedreich Ataxia?
por: Berntsson, Shala Ghaderi, et al.
Publicado: (2013)

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

COVID-19 in multiple sclerosis: The Dutch experience
por: Loonstra, Floor C, et al.
Publicado: (2020)

Increased Concentrations of Glutamate and Glutamine in Normal-Appearing White Matter of Patients with Multiple Sclerosis and Normal MR Imaging Brain Scans
por: Tisell, Anders, et al.
Publicado: (2013)

Dynamic Changes in Brain Mesenchymal Perivascular Cells Associate with Multiple Sclerosis Disease Duration, Active Inflammation, and Demyelination
por: Iacobaeus, Ellen, et al.
Publicado: (2017)

Validation of multiple sclerosis diagnoses in the Swedish National Patient Register
por: Murley, Chantelle, et al.
Publicado: (2019)

A novel radiological classification system for cerebral gliomas: The Brain-Grid
por: Latini, Francesco, et al.
Publicado: (2019)

The Expression of VEGF-A Is Down Regulated in Peripheral Blood Mononuclear Cells of Patients with Secondary Progressive Multiple Sclerosis
por: Iacobaeus, Ellen, et al.
Publicado: (2011)

Multiple Sclerosis, COVID-19 and Vaccines: Making the Point
por: Toscano, Simona, et al.
Publicado: (2021)

Translation and Validation of the Swedish Version of the Tilburg Frailty Indicator
por: Mazya, Amelie Lindh, et al.
Publicado: (2023)

Experiences of Injuries and Injury Reporting among Swedish Skydivers
por: Jong, Mats, et al.
Publicado: (2014)

COVID-19 in multiple sclerosis: Experience from North India
por: Khurana, Dheeraj, et al.
Publicado: (2021)

COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022)

Patient safety when receiving telephone advice in primary care – a Swedish qualitative interview study
por: Berntsson, Karin, et al.
Publicado: (2022)

Experience with the COVID-19 AstraZeneca vaccination in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2021)

Comparison of Swedish nurses’ attitudes toward involving families in care over a decade
por: Konradsen, Hanne, et al.
Publicado: (2022)

Older Persons’ Views on Important Values in Swedish Home Care Service: A Semi-Structured Interview Study
por: Olsen, Marie, et al.
Publicado: (2022)

COVID‐19 in lung transplant recipients: an overview of the Swedish national experience
por: Magnusson, Jesper M., et al.
Publicado: (2021)

Short and Long Term Clinical and Immunologic Follow up after Bone Marrow Mesenchymal Stromal Cell Therapy in Progressive Multiple Sclerosis—A Phase I Study
por: Iacobaeus, Ellen, et al.
Publicado: (2019)

Association between Change in Normal Appearing White Matter Metabolites and Intrathecal Inflammation in Natalizumab-Treated Multiple Sclerosis
por: Mellergård, Johan, et al.
Publicado: (2012)

Did it hurt? COVID-19 vaccination experience in people with multiple sclerosis
por: Allen-Philbey, K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f7fffmoota77gpgsajjd3cjo96